News | March 04, 2025
Biocon Academy conducts 9th Graduation Day
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
The Alathur facility specializes in the production of Cephalosporin antibiotics
Vaccine helps protect against five common disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y)
The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
Profit after Taxes registered strong growth of 22% to Rs. 162 crores versus Rs. 134 crores in Q3 FY24
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
Revenue from Operations for Q3 FY25 was Rs. 454.33 crore,
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
The company remains focused on strengthening its direct retail presence and expanding its reach to more customers across India.
Subscribe To Our Newsletter & Stay Updated
